Iceland· IS-EU/1/20/1494/001-002
Leqvio
A inclisiran product containing inclisiranum inn natríum, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Inclisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AX16 (inclisiran), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Inclisiran · ATC C10AX16
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Inclisiranum INN natríum
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- C10AX16
- ATC class
- Inclisiran
- Defined daily dose
- 1.6 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean0261091,5 ml x1 áfsprISK 375651
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inclisiran in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLEQVIO 284 mg SOLUCION INYECTABLE EN JERINGA PRECARGADANovartis Europharm Limited
- NorwayLeqvioOrifarm AS
- SwedenLeqvio 284 mg Injektionsvätska, lösning i förfylld sprutaNovartis Europharm Limited
- IrelandLeqvio 284 mg solution for injection in pre-filled syringeNovartis Europharm Limited
- ItalyLEQVIO*1 siringa preriempita SC 1,5 ml 284 mg 189 mg/ml con dispositivo di protezione dell'agoNOVARTIS EUROPHARM LTD
- NetherlandsLeqvio 284 mg oplossing voor injectie in een voorgevulde spuitNovartis Europharm Limited
- PolandLeqvioNovartis Europharm Limited
- CanadaLEQVIONOVARTIS PHARMACEUTICALS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Leqvio
- Norway · Leqvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/79bdfbba-6d19-4a9c-b9a8-81a958224f72 GET /v1/drugs/79bdfbba-6d19-4a9c-b9a8-81a958224f72?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "C10AX16",
"marketed": true,
"strength": "284 mg",
"ma_number": "EU/1/20/1494/001-002",
"substance": "Inclisiranum INN natríum",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44174"
}See everything about inclisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.